至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Evolution of the hemagglutinin protein of new pandemic H1N1 virus: Maintaining optimal receptor binding by compensatory substitutions.

J Virol.. 2013-10; 
de Vries RP, de Vries E, MartÍnez-Romero C, McBride R, van Kuppeveld F, Rottier PJ, GarcÍa-Sastre A, Paulson JC, de Haan CA. Virology Division, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands.
Products/Services Used Details Operation

摘要

Pandemic influenza A H1N1 virus (pH1N1) emerged in 2009. In the subsequent four years, it acquired several genetic changes in its hemagglutinin (HA). Mutations may be expected while adapting to the human host or upon evasion from adaptive immune responses. However, pH1N1 does not display any major antigenic changes so far. We examined the effect of the amino acid substitutions most frequently occurring in the pH1N1 HA protein before 04-01-2012, on the receptor-binding properties of the virus by using recombinant soluble HA trimers. Two changes (S186P and S188T) were shown to increase receptor-binding avidity of HA whereas two others (A137T and A200T) decreased binding avidity. Construction of an HA protein tree... More

关键词